From GlobeNewswire: 2024-09-03 16:30:00

Intellia Therapeutics, Inc. awarded inducement grants to five new employees under its 2024 Inducement Plan. The grants include non-qualified stock options, time-based restricted stock units, and performance-based restricted stock units. These awards were granted outside of the company’s stockholder-approved equity incentive plans. All equity vesting is subject to continued service by employees through applicable vesting dates. Intellia Therapeutics is a leading gene editing company focused on CRISPR-based therapies to revolutionize medicine. The company’s programs aim to edit disease-causing genes both inside and outside the human body. Learn more at intelliatx.com.



Read more at GlobeNewswire: Intellia Therapeutics Reports Inducement Grants under